Heraldo de Madrid - Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

NYSE - LSE

RBGPF	0.88%	73.92	$
CMSD	1%	23.95	$
GSK	0.27%	40.19	$
RIO	2.22%	62.69	$
RELX	0.52%	48.44	$
NGG	-0.03%	71.41	$
VOD	0.5%	11.92	$
RYCEF	0.5%	14.06	$
SCS	2.42%	16.5	$
BTI	-1.3%	58.51	$
CMSC	1.26%	23.75	$
JRI	0.89%	13.45	$
BCC	7.18%	91.22	$
AZN	0.63%	80.97	$
BCE	-0.9%	25.49	$
BP	1.99%	34.74	$

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

BOULEVARD 23.01.2025

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

LAVAL, QC / ACCESS Newswire / January 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, February 19, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Text size:

Conference Call Details

Date:	Wednesday, February 19, 2025
Time:	5:00 p.m. U.S. EST
Webcast:	http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

To participate in the live Q&A session, please register using this link to receive an email confirming your registration.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.

###

Investor Contact:
Garen Sarafian
[email protected]
(877) 281-6642 (toll-free)

Media Contact:
Katie Savastano
[email protected]
(908) 541-3785

SOURCE: Bausch Health Companies Inc.

View the original press release on ACCESS Newswire

Y.Robles--HdM